US equities
|
MU
$685.11
▲+4.38%
NVDA
$186.26
▲+2.57%
AMD
$436.89
▲+8.03%
SNDK
$826.50
▲+2.49%
SPCX
$130.97
▲+5.95%
TSLA
$358.44
▲+4.29%
AAPL
$343.97
▼-0.06%
MSFT
$533.49
▼-0.46%
MU
$685.11
▲+4.38%
NVDA
$186.26
▲+2.57%
AMD
$436.89
▲+8.03%
SNDK
$826.50
▲+2.49%
SPCX
$130.97
▲+5.95%
TSLA
$358.44
▲+4.29%
AAPL
$343.97
▼-0.06%
MSFT
$533.49
▼-0.46%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Fortress Biotech, Inc. - Common Stock
(NQ:
FBIO
)
1.845
+0.005 (+0.27%)
Delayed Quote
Updated: 12:51 PM EST, Nov 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Fortress Biotech, Inc. - Common Stock
Lindsay Rosenwald’s Fortress Bio (NASDAQ: FBIO) Spotlight on 2024 Milestones from Subsidiaries
February 05, 2024
Via
Get News
Lindsay Rosenwald’s Fortress Bio (NASDAQ: FBIO) Spotlight on 2024 Milestones from Subsidiaries
February 02, 2024
New York, Feb 2, 2024 - (Plato Data via 500NewsWire) -- Fortress Biotech (Fortress Bio), a unique biotech company led by industry veteran Dr. Lindsay Rosenwald, focused on identifying, in-licensing and...
Via
TheNewswire.com
Fortress Biotech Inc. (NASDAQ: FBIO) Leading the Way in Monday Trading Based on Percentage Gain
November 20, 2023
Via
Investor Brand Network
Fortress Bio’s Portfolio Of Marketed Drugs Could Soon See Three Additions
October 06, 2022
Fortress Biotech Inc. (NASDAQ: FBIO) is a biopharmaceutical company focused on developing a range of high-potential treatments on its own and through its growing portfolio of subsidiaries and partner...
Via
TheNewswire.com
Fortress Biotech, Inc. (NASDAQ: FBIO) Featured in Virtual Coverage of the 34th Annual Roth Conference
March 16, 2022
Via
Investor Brand Network
36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022
May 16, 2022
RALEIGH, NC / ACCESSWIRE / May 16, 2022 / The Spring into Action- Best Ideas Virtual Investor Conference will take place on May 16th - 20th, 2022, where 36 SmallCap, MicroCap and NanoCap public...
From
MicroCap Rodeo
Via
AccessWire
36 of the Best Ideas Companies to Present at the 2nd Annual Winter Wonderland Virtual Investor Conference on February 8th - 11th, 2022
January 28, 2022
RALEIGH, NC / ACCESSWIRE / January 28, 2022 / The Winter Wonderland Best Ideas Virtual Investor Conference will take place on February 8th - 11th, 2022, where 36 SmallCap, MicroCap and NanoCap public...
From
MicroCap Rodeo
Via
AccessWire
Aegis Capital Corp. acted as Sole Bookrunner on a $2.6 Million Public Offering of Common Stock for Avenue Therapeutics (NASDAQ: ATXI)
November 12, 2021
NEW YORK, NY / ACCESSWIRE / November 12, 2021 / Aegis Capital Corp. acted as Sole Bookrunner on a $2.6 Million Public Offering of Common Stock for Avenue Therapeutics (NASDAQ:ATXI). About Avenue...
From
Aegis Capital Corp.
Via
AccessWire
Topics
Retirement
35 of the Best Ideas Companies to Present at the Summer Solstice - Best Ideas from the Buy-Side Virtual Investor Conference on June 1-4, 2021
May 27, 2021
RALEIGH, NC / ACCESSWIRE / May 27, 2021 / The Summer Solstice - Best Ideas from the Buy-Side will take place on June 1-4, 2021, where 35 SmallCap, MicroCap and NanoCap public companies will be...
From
MicroCap Rodeo
Via
AccessWire
